22 results
F-1/A
EVAX
Evaxion Biotech A/S
30 Jan 24
Registration statement (foreign) (amended)
3:16pm
exceed our insurance coverage, our financial condition would be adversely affected. In the event of contamination or injury, we could be held liable … of our product candidates could result in patient injury or death. Any of these occurrences may materially harm our business, financial condition
F-1
EVAX
Evaxion Biotech A/S
12 Jan 24
Registration statement (foreign)
5:17pm
exceed our insurance coverage, our financial condition would be adversely affected. In the event of contamination or injury, we could be held liable … or managing the potential side effects of our product candidates could result in patient injury or death. Any of these occurrences may materially harm our
424B4
1n5wrg
5 Nov 21
Prospectus supplement with pricing info
4:47pm
F-1/A
61osnh
3 Nov 21
Registration statement (foreign) (amended)
7:50am
F-1
26s4p
26 Oct 21
Registration statement (foreign)
7:02am
6-K
EX-99.2
txb ct2jbra295unv
25 Oct 21
Evaxion Biotech Announces Clinical Collaboration to Evaluate Lead Product Candidate with KEYTRUDA® (pembrolizumab) in Patients with Melanoma
6:00am
DRS
wlm8a4
25 Jun 21
Draft registration statement
12:00am
20-F
qyjb5astj
7 Apr 21
Annual report (foreign)
4:31pm
424B4
d4h9apa
5 Feb 21
Prospectus supplement with pricing info
4:53pm
F-1/A
ga8luk
1 Feb 21
Registration statement (foreign) (amended)
4:56pm
F-1/A
slz6ip
25 Jan 21
Registration statement (foreign) (amended)
7:01am
F-1/A
jbwv rxfc5
19 Jan 21
Registration statement (foreign) (amended)
5:05pm
F-1
EX-10.1
gvfmw1bmds05xfw8le
8 Jan 21
Registration statement (foreign)
4:54pm
F-1
3d149fm98x
8 Jan 21
Registration statement (foreign)
4:54pm
DRS/A
EX-10.1
3xv s41eqj
4 Jan 21
Draft registration statement (amended)
12:00am
DRS/A
nixjp4rwpgc
4 Jan 21
Draft registration statement (amended)
12:00am
DRS/A
inb t363p
16 Dec 20
Draft registration statement (amended)
12:00am